Journal
CLINICAL CANCER RESEARCH
Volume 17, Issue 5, Pages 949-951Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-10-3279
Keywords
-
Categories
Funding
- NCI NIH HHS [P30 CA016520-34, P30 CA016520] Funding Source: Medline
Ask authors/readers for more resources
Advances in statistical modeling and analysis technology have improved our ability to derive valid inferences from tumor xenograft experiments. Further challenges in this area include the modeling of intertumor heterogeneity and the development of robust statistical models that describe key parameters in the underlying tumor biology. Clin Cancer Res; 17(5); 949-51. (C)2011 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
